title: Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.
authors.affiliation: *IBD Center, Center for Interventional Endoscopy, Florida Hospital, Orlando, Florida †Department of Gastroenterology, University of Florida, Gainesville, Florida.
authors.forename: Udayakumar
authors.initials: U
authors.lastname: Navaneethan
authors.forename: Timothy
authors.initials: T
authors.lastname: Edminister
authors.forename: Xiang
authors.initials: X
authors.lastname: Zhu
authors.forename: Kiran
authors.initials: K
authors.lastname: Kommaraju
authors.forename: Sarah
authors.initials: S
authors.lastname: Glover
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008875:Middle Aged; D011379:Prognosis; D012449:Safety
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; C543529:vedolizumab